119.24
price up icon0.90%   1.0284
 
loading
前日終値:
$118.21
開ける:
$117.515
24時間の取引高:
2.89M
Relative Volume:
0.45
時価総額:
$147.95B
収益:
$28.80B
当期純損益:
$6.31B
株価収益率:
23.72
EPS:
5.0273
ネットキャッシュフロー:
$9.37B
1週間 パフォーマンス:
+2.14%
1か月 パフォーマンス:
+4.12%
6か月 パフォーマンス:
+12.00%
1年 パフォーマンス:
+40.24%
1日の値動き範囲:
Value
$116.62
$119.33
1週間の範囲:
Value
$115.75
$119.33
52週間の値動き範囲:
Value
$84.80
$121.83

Gilead Sciences Inc Stock (GILD) Company Profile

Name
名前
Gilead Sciences Inc
Name
セクター
Healthcare (1144)
Name
電話
(650) 574-3000
Name
住所
333 LAKESIDE DR, FOSTER CITY, CA
Name
職員
17,600
Name
Twitter
@GileadSciences
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
GILD's Discussions on Twitter

GILD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
GILD
Gilead Sciences Inc
119.24 146.68B 28.80B 6.31B 9.37B 5.0273
Drug Manufacturers - General icon
LLY
Lilly Eli Co
814.99 734.56B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
190.56 459.75B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
229.44 406.84B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
130.20 249.96B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
85.06 214.06B 63.43B 16.42B 14.72B 6.4861

Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-19 アップグレード Daiwa Securities Neutral → Outperform
2025-08-08 アップグレード Truist Hold → Buy
2025-07-25 アップグレード Needham Hold → Buy
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-03-04 繰り返されました Oppenheimer Outperform
2025-02-18 アップグレード Deutsche Bank Hold → Buy
2025-02-13 アップグレード DZ Bank Hold → Buy
2025-01-10 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました BofA Securities Buy
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Buy
2024-11-08 ダウングレード Maxim Group Buy → Hold
2024-10-21 アップグレード Leerink Partners Market Perform → Outperform
2024-10-17 開始されました Bernstein Outperform
2024-10-07 アップグレード Wells Fargo Equal Weight → Overweight
2024-07-08 アップグレード Raymond James Mkt Perform → Outperform
2024-05-01 繰り返されました Maxim Group Buy
2024-04-24 アップグレード HSBC Securities Reduce → Hold
2024-02-22 ダウングレード Truist Buy → Hold
2023-11-09 開始されました Deutsche Bank Hold
2023-09-08 アップグレード BofA Securities Neutral → Buy
2023-09-06 開始されました HSBC Securities Reduce
2023-07-24 繰り返されました Barclays Equal Weight
2023-05-16 アップグレード BMO Capital Markets Market Perform → Outperform
2023-04-28 再開されました Piper Sandler Overweight
2023-01-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-12-13 再開されました BofA Securities Neutral
2022-12-09 ダウングレード DZ Bank Buy → Hold
2022-10-31 アップグレード Barclays Underweight → Equal Weight
2022-10-28 繰り返されました BMO Capital Markets Market Perform
2022-10-28 繰り返されました Cowen Outperform
2022-10-28 繰り返されました JP Morgan Overweight
2022-10-28 繰り返されました Jefferies Buy
2022-10-28 アップグレード Piper Sandler Neutral → Overweight
2022-10-28 繰り返されました RBC Capital Mkts Outperform
2022-10-28 アップグレード Truist Hold → Buy
2022-10-28 繰り返されました Wells Fargo Equal Weight
2022-10-04 アップグレード JP Morgan Neutral → Overweight
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-28 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-02-02 繰り返されました BMO Capital Markets Outperform
2022-02-02 繰り返されました BofA Securities Neutral
2022-02-02 繰り返されました RBC Capital Mkts Outperform
2022-02-02 繰り返されました Truist Hold
2022-02-02 繰り返されました Wells Fargo Equal Weight
2022-01-28 アップグレード Argus Hold → Buy
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Neutral
2021-11-19 アップグレード BMO Capital Markets Market Perform → Outperform
2021-11-19 再開されました Piper Sandler Neutral
2021-10-20 再開されました Cowen Outperform
2021-07-30 繰り返されました BMO Capital Markets Market Perform
2021-07-30 繰り返されました RBC Capital Mkts Outperform
2021-04-01 アップグレード Bernstein Mkt Perform → Outperform
2021-03-30 アップグレード Redburn Neutral → Buy
2021-01-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-01-04 アップグレード Guggenheim Neutral → Buy
2020-11-03 再開されました Morgan Stanley Equal-Weight
2020-10-28 開始されました UBS Neutral
2020-09-30 再開されました Jefferies Buy
2020-09-15 アップグレード Maxim Group Hold → Buy
2020-07-31 繰り返されました Credit Suisse Neutral
2020-07-31 繰り返されました Morgan Stanley Equal-Weight
2020-07-31 繰り返されました Piper Sandler Overweight
2020-07-31 繰り返されました RBC Capital Mkts Outperform
2020-07-31 繰り返されました SunTrust Hold
2020-07-31 繰り返されました Wells Fargo Equal Weight
2020-07-20 アップグレード Credit Suisse Underperform → Neutral
2020-06-03 アップグレード SVB Leerink Mkt Perform → Outperform
2020-05-26 アップグレード SunTrust Sell → Hold
2020-05-01 ダウングレード JP Morgan Overweight → Neutral
2020-05-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-05-01 ダウングレード SunTrust Hold → Sell
2020-04-27 ダウングレード UBS Buy → Neutral
2020-04-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-04-20 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 ダウングレード CFRA Hold → Sell
すべてを表示

Gilead Sciences Inc (GILD) 最新ニュース

pulisher
09:49 AM

Chinese Research Org. Says Gilead Infringed COVID Patent - Law360

09:49 AM
pulisher
05:19 AM

Gilead and Arcus see survival boost with gastric cancer combo - The Pharma Letter

05:19 AM
pulisher
Oct 13, 2025

Gilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 Months - Benzinga

Oct 13, 2025
pulisher
Oct 13, 2025

Gilead to present promising data for Trodelvy in breast cancer at ESMO - Investing.com

Oct 13, 2025
pulisher
Oct 13, 2025

Gilead to present Trodelvy breast cancer data at ESMO 2025 - StreetInsider

Oct 13, 2025
pulisher
Oct 13, 2025

Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades' - Benzinga

Oct 13, 2025
pulisher
Oct 13, 2025

Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025 - Business Wire

Oct 13, 2025
pulisher
Oct 13, 2025

Yousif Capital Management LLC Sells 2,855 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Survival data boost prospects for Gilead, Arcus TIGIT drug in gastric cancer - FirstWord Pharma

Oct 13, 2025
pulisher
Oct 13, 2025

ADAPT: Accelerating Disability Awareness & Progress Together - Gilead Sciences

Oct 13, 2025
pulisher
Oct 12, 2025

OFI Invest Asset Management Sells 86,817 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Transcendent Capital Group LLC Invests $432,000 in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Gilead Sciences, Inc. $GILD Position Boosted by Sivik Global Healthcare LLC - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Natural Investments LLC Has $317,000 Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Lmcg Investments LLC Has $1.97 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 12, 2025
pulisher
Oct 11, 2025

How Investors Are Reacting To Gilead Sciences (GILD) Extending Biktarvy Exclusivity and Advancing HIV, Oncology Pipeline - Yahoo

Oct 11, 2025
pulisher
Oct 11, 2025

Conning Inc. Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Fourpath Capital Management LLC Reduces Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

3Chopt Investment Partners LLC Acquires 3,318 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Gilead Sciences, Inc. $GILD Shares Sold by Aberdeen Group plc - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Gilead Sciences (NASDAQ:GILD) Stock Unloaded Rep. Val T. Hoyle - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Gilead: Incorporating Longer Biktarvy Runway - Morningstar

Oct 10, 2025
pulisher
Oct 10, 2025

Gilead's HIV Portfolio Has a Long Runway and Supports a Wide Moat - Morningstar

Oct 10, 2025
pulisher
Oct 10, 2025

Cantor Fitzgerald Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Blair William & Co. IL Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Trifecta Capital Advisors LLC Has $339,000 Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

TFR Capital LLC. Makes New $283,000 Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Callan Family Office LLC Purchases 63,300 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Tectonic Advisors LLC Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Maryland State Retirement & Pension System Increases Position in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

US Bancorp DE Sells 22,670 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Vontobel Holding Ltd. Lowers Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can Gilead Sciences Inc. hit a new high this monthWeekly Investment Report & Fast Moving Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time social sentiment graph for Gilead Sciences Inc.July 2025 Setups & Weekly Breakout Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025 - BioSpace

Oct 09, 2025
pulisher
Oct 09, 2025

"Taking possibility back" across oncology’s toughest frontiers - statnews.com

Oct 09, 2025
pulisher
Oct 09, 2025

Gilead Sciences To Release Third Quarter 2025 Financial Results On Thursday, October 30, 2025 - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

Gilead blocks HIV drug generics for more than 10 years - Life Sciences Intellectual Property Review

Oct 09, 2025
pulisher
Oct 09, 2025

A Look Inside Gilead's Inflammation Pipeline - Gilead Sciences

Oct 09, 2025
pulisher
Oct 09, 2025

Cantor Fitzgerald Adjusts PT on Gilead Sciences to $135 From $129, Maintains Overweight Rating - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Can Gilead Sciences Inc. stock deliver consistent earnings growthMarket Trend Summary & Real-Time Market Sentiment Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Fluent Financial LLC Raises Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Kingswood Wealth Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Gilead Sciences (NASDAQ:GILD) Given "Buy (B)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Citigroup Maintains Gilead Sciences (GILD) Buy Recommendation - Nasdaq

Oct 08, 2025
pulisher
Oct 08, 2025

Gilead Sciences Rallies After Trump Partnership News Is the Growth Story Just Beginning - Yahoo Finance

Oct 08, 2025
pulisher
Oct 08, 2025

GILD: Citigroup Raises Price Target for Gilead Sciences Amid Buy Rating | GILD Stock News - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Greed Is a Hell of a Drug - Truthdig

Oct 08, 2025
pulisher
Oct 08, 2025

Multiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances - GlobeNewswire Inc.

Oct 08, 2025
pulisher
Oct 08, 2025

RBC Capital raises Gilead Sciences stock price target to $100 on Yeztugo launch - Investing.com

Oct 08, 2025

Gilead Sciences Inc (GILD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general PFE
$24.69
price down icon 0.23%
$295.36
price up icon 0.89%
drug_manufacturers_general SNY
$48.68
price down icon 0.24%
drug_manufacturers_general NVO
$56.73
price down icon 1.31%
drug_manufacturers_general MRK
$85.06
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):